Product Pathways
BCP0014 ADL5859
ADL-5859 is an agonist agents that selectively stimulate the δ-opioid receptor with potential application in a wide range of inflammatory, neuropathic and acute pain conditions.
BCP0101 Pimecrolimus
Inhibitor of inflammatory cytokine secretion.
BCP0111 SB202190
SB202190 (FHPI) is a potent p38 MAPK inhibitor targeting p38α and p38β with IC50 of 50 nM and 100 nM, respectively.
BCP0112 SB203580
SB203580 is a p38 MAPK inhibitor with IC50 of 0.3-0.5 μM and blocks PKB phosphorylation with IC50 of 3-5 μM.
BCP0071 Malotilate
Malotilate is a liver protein metabolism improved compound.
BCP0131 LY315920(Varespladib)
Varespladib is a selective inhibitor of human, group IIA, nonpancreatic secretory PLA2 (sPLA2).
BCP0155 Resveratrol
Resveratrol is a phytoalexin produced naturally by several plants with anti-cancer, anti-inflammatory, blood-sugar-lowering and other beneficial cardiovascular effects .
BCP0166 STA5326
Potent and orally active inhibitor of the cytokines interleukin-12 (IL-12), and interleukin-23 (IL-23) production.
BCP0190 Triptolide(PG490)
Inhibits cytokine-induced gene expression via inhibition of NF-κB transcriptional activity.
BCP0252 AMG-47a
AMG-47a is an orally bioavailable potent inhibitor of Lck and T cell proliferation.
第一页 1 2 3 4 5 6 7 8 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.